This year, the municipal party committee and the city government promulgated a on speeding up the emerging industry development of the implementation opinions ", the pharmaceutical industry as one of nine revitalization industry to grasp. Zhuhai's food and drug administration, actively adopt effective measures to carry out the "construction medicine powerful city pensions" activities, promotes the healthy growth of the industry. This year, the city in September 1 - pharmaceutical industry in mass diet drug quality improvement, under the precondition of achieved sales revenue 180.98 million yuan, tax turnover, gross amounts to 0.904 billion yuan, a year-on-year growth 23.3% respectively, industry and 28.8% quantitatively the the front rank.
This year, in order to further promote the adjustment of industry structure and economic development mode change, zhuhai on medicine industry development put forward to big ideas, making the national important chemical API, TCM production base, by 2015, strive to achieve advocate business wu income 100 billion yuan. Around the development goal, zhuhai's food and drug supervision system issued to carry out the "12454" thinking measures, promoted the medicine industry transformation and upgrade and sustained growth in zhuhai as soon as possible by medical leading market to medicine powerful city leap.
Promote medicine industry structure adjustment. Zhuhai according to "build area, boosting districts, expand two garden, the key support eight development groups" mentality, accelerate medicine industry centralization, intensive, collectivize development, three years completed investment 31 million yuan RMB, the YaoXie production sales income over 100 million yuan, business sales over 150 million yuan. To actively promote pharmaceutical enterprise m&a, strive to contributing weifang pharmaceutical factory and YuBin investment company's cooperation, universal ShiPuLe company and shandong Wisconsin high group and jilin correction pharmaceutical cooperation. Focus on supporting YaoWang pharmaceutical, medical, WoHua investec biopharmaceuticals, lai hong pharmaceutical, weifang pharmaceutical factory etc pharmaceuticals enterprise development, key cultivation eight large-scale high-end preparations of leading enterprises. Support to encourage enterprise technical renovation, and promote enterprise production mode from the traditional to the modern transformation, from the extensive style of fine type change, from labor-intensive to knowledge-intensive transformation.
Promote medical product structure adjustment. Prominent incubation center construction, establish the drug r&d alliances. In shandong WoHua pharmaceutical institute, 3d r&d center, weifang kang hundred rui medicine for bibcock, three years in mind cerebrovascular series drugs, in vitro diagnostic reagent, fall hematic fat and reduce blood sugar series drugs etc varieties of r&d, strive to have 10 varieties for the examination and approval procedures. The key support fukang pharmaceutical, pharmaceutical, new and strange countries into three-dimensional biological, pharmaceutical, happiness pharmaceutical company, shu a pharmaceutical enterprise, quicken the biological medicine field and hi-tech product project of product development and registered progress. Actively support YaoWang pharmaceutical of infusion series products, WoHua medicine by heart can shu piece mainly of proprietary products, investec biopharmaceutical products such as antibiotic continuously increasing yield existing varieties. Fully supporting development of Chinese herbal medicine and Chinese medicine extraction, construction of modern production base, proprietary Chinese medicine built national cerebrovascular drug production base. At present, the main products of shouguang fukang pharmaceutical TMP apis, anqou took pharmaceutical leading products acetaminophen in the scale of production are occupies the first.
Promote pharmaceutical circulation structure adjustment. The key support shandong haiwang galaxy medicine, shandong KangHui medicine, shandong xin victor, shandong far east pharmaceutical etc. Large pharmaceutical circulation enterprise development, accelerate kuiwen medicine logistics park's construction pace, cultivate 2 business scale 20 billion yuan of above, 10 business scale 2 billion yuan of above of modern drug logistics enterprises. The key support shandong haiwang stars people kang, weifang people blessed 10 business outlets etc in more than 50 stores chain enterprises, emphatically supporting 2 home business store development to 80 home above, in a provincial key development enterprise ranks. Support the development of rural drug retail enterprise, encourage and support large pharmaceutical chain enterprises outspread, convenient to rural farmers buy medicines.
Promote medical market structure adjustment. Active help enterprises to develop international market, key supporting fukang pharmaceutical, took pharmaceutical company, shandong days force pharmaceutical company, two cities such as pharmacy, weifang pharmaceutical production enterprise and apis shandong kanglilai, weifang huaxing, universal ShiPuLe etc medical device manufacturing enterprise in Europe, America and southeast Asia market, consolidate and develop the Middle East, Africa and other emerging markets. Actively support enterprises expand domestic market, focus on the instruction help zhuhai 8 essential medicine production enterprises, improve market share. The key support large pharmaceutical circulation enterprise development and realizing the rapid expansion of scale.
from"http://info.pharmacy.hc360.com/2010/12/020859220279.shtml" |
